Angion Biomedica
Last update: March 8, 2021
Biotechnology
United States (USA)
Its 8 main executives
Create an alert
to follow the executive moves at Angion Biomedica.
Most searched biographies at Angion Biomedica
- Jay Venkatesan, Chief Executive Officer and Director
- Karen Wilson, Director
- Allen Nissenson, Director
Click on an executive to view his biography >
Latest M&A news in Biotechnology.
DiaSorin has announced the acquisition of Luminex (posted on Apr 16, 2021).
Bio-Techne has acquired Asuragen (posted on Apr 7, 2021).
EQT has announced the acquisition of Cerba Healthcare (posted on Apr 1, 2021).
Other contacts in the Biotechnology industry
Latest news about Angion Biomedica
Angion Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results – Angion
Angion Completes Enrollment in Phase 2 Study of ANG-3777 for Acute Lung Injury in Patients with COVID-19 Associated Pneumonia – Angion
Angion Announces Partial Waiver of Certain Lock-up Restrictions – Angion
Angion to Participate in Upcoming March Investment Conferences – Angion
Angion Biomedica Corp. Announces Pricing of Initial Public Offering of Common Stock and Concurrent Private Placement – Angion
Angion Biomedica on Wikipedia, Google News & Yahoo Finance
Angion Biomedica on LinkedIn, Twitter & YouTube
Angion Biomedica has 1,651 competitors including Biogen (United States (USA)), Eurofins (France) and Actelion (Switzerland).
